Amanda Melina Grittner

Suggest Changes
  • Citations Per Year
Learn More
BACKGROUND Prostate cancer is the most common noncutaneous malignancy in men in the United States. Patients with metastatic castration-resistant prostate cancer (mCRPC) may be treated with secondary(More)
PURPOSE Comparative data on rehospitalization patterns and associated institutional costs after inpatient treatment with paliperidone palmitate or oral antipsychotic therapy are reported. METHODS A(More)
  • 1